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InthisstudywedemonstratedthatΔCaecm33doublemutantshowedreducedbioﬁlmformationandcauseslessdamagetogingival
mucosa tissues. This was conﬁrmed by the reduced level of necrotic cells and Bax/Bcl2 gene expression as apoptotic markers.
In contrast, parental and Caecm33 mutant strains decreased basement membrane protein production (laminin 5 and type IV
collagen). We thus propose that ECM33 gene/protein represents a novel target for the prevention and treatment of infections
caused by Candida.
1.Introduction
Candida species are the most frequent cause of life-threaten-
ing invasive fungal infections in the immunocompromised
host [1, 2]. Under predisposing conditions, C. albicans mul-
tiplies and penetrates the host tissue to cause inﬂammation
and tissue destruction [3]. C. albicans adherence to host cells
is therefore the ﬁrst step in the initiation of infection, as this
enables the organism to evade the normal ﬂushing mecha-
nisms of body secretions [4].
The Candida cell wall is the initial point of contact and
interaction with host tissues. This wall consists of a com-
plex structure that houses a network of polysaccharides (pri-
marily β-glucans and chitin) in which various proteins such
as glycosylphosphatidylinositol (GPI) interact [5]. The key
function of GPI proteins in Candida biogenesis and main-
tenance of the fungus cell wall involves ECM33 gene [6].
ECM33 protein is required for normal cell wall integrity
and the yeast-to-hyphae transition in vitro [7]. C. albicans
Caecm33Δ/Caecm33Δ mutant showed blastospores that were
ﬂocculatedandwerelargerthanthoseofthewild-typestrain.
Caecm33Δ/Caecm33Δ mutant displayed delayed hyphal for-
mationandshowedattenuatedvirulenceinthemousemodel
of hematogenously disseminated candidiasis [8].
The absence of ECM33 gene may also prevent Candida
from aﬀecting the oral mucosa. Oral epithelium interacts
with connective tissue via basement membrane (BM) pro-
teins that contribute to body integrity.
Oral mucosa contains a highly complex stratiﬁed epithe-
lia that protects the body from physical and chemical dam-
age, infection, dehydration, and heat loss through interac-
tions with the mesenchymal tissue via basement membrane
(BM) proteins [9–11]. The BM is a thin layer of complex ex-
tracellular matrix that forms the support structure on which
epithelial cells grow. This layer also provides mechanical
sup-port,divides tissueintocompartments,andsignificantly
inﬂuences cellular behavior [12]. Two major components of
the BM are type IV collagen and laminin. Type IV collagen
forms a network that confers the distinctive mechanical
stability known to the BM [13]. Laminin binds to collagen2 Mediators of Inﬂammation
IV to constitute a second network by interacting with nido-
gen. Laminin 5 is speciﬁc to the basement membrane under-
lying the squamous epithelium and mucosa [14]. Its primary
role is to modulate stable epithelial cell attachment through
interactions with integrins α3β1 and α6β4 [15].
TheinteractionbetweenCandidaandtheoralepithelium
is believed to be one of the most important initial events
in the prevention or development of candidiasis [18]. How-
ever, following contact with C. albicans, and under certain
circumstances such as reduced innate immunity, C. albicans
may occasionally become pathogenic and induce lesions on
the oral mucosa [19, 20]. This may occur through a dereg-
ulation of BM protein synthesis and deposition, which in
turn induces a breakdown of oral homeostasis and, conse-
quently, systemic infection [21, 22]. Tissue structure and BM
protein deregulation may occur through apoptotic processes
involving inducer (Bax, Bcl-xS, Bad) and inhibitor (Bcl-2,
Bcl-xL) genes [23]. Indeed, host cell death following micro-
bialinfectionistypicallyrecognizedasnecrotic,apoptotic,or
pyroptotic [24–26]. While necrosis is characterized as acci-
dental cell death as the result of physical damage, apoptosis
and pyroptosis are strictly regulated genetic and biochemical
self-destruction programs that are critical during develop-
ment and tissue homeostasis as well as in modulating the
pathogenesis of a variety of infectious diseases [27]. A recent
study reported that C. albicans stimulated the oral epithelial
signaling pathways that promote early apoptotic cell death
through the activation of cellular caspases, followed by late
necrosis [22].
Considering the key role of oral mucosa in preventing/
controlling Candida pathogenesis, and given the adhesion,
whichistheﬁrststageof bioﬁlmformationof Candidatothe
tissue through speciﬁc proteins such as ECM33,w es o u gh tt o
investigate the role of ECM33 gene on Candida bioﬁlm for-
mation, and its interaction with oral mucosa tissue. The cen-
tralhypothesisofthisstudyisthatECM33geneisinvolvedin
Candida virulence leading to tissue damage and facilitating
the onset of candidiasis. To test this hypothesis, we examined
the ability of ECM33 isogenic strains of C. albicans to form
bioﬁlms in vitro on a catheter-associated bioﬁlm model in
order to induce tissue damage, cell necrosis, apoptosis sig-
nalling molecule (Bax and Bcl2) activation, and laminin 5
and type IV collagen modulation. To move our study closer
totheclinicalsetting,weusedanengineeredhumanoralmu-
cosa model, as previously described [4].
2.MaterialsandMethods
2.1. Candida Strains. Table 1 presents the Candida albicans
strains used in this study. These strains were generously
donated by Dr. C. Gil (Madrid, Spain). The parental
(CAF2) C. albicans strain was genotypically identiﬁed as
URA3/Δura3::imm43 [16]. Each Candida strain was cultured
on Sabouraud dextrose agar plates (Becton Dickinson,
Oakville, ON, Canada) at 30◦C. To prepare the C. albi-
cans suspension, one colony was used to inoculate 10mL
of Phytone-peptone medium (Becton Dickinson) supple-
mented with 0.1% glucose and 80mg/L of uridine at pH 5.6.
The cultures were grown under shaking conditions in a
water bath for 18h, after which time the Candida cells were
collected, washed with PBS, and resuspended in the same
buﬀer to a density of 1 × 107 cells/mL to obtain a standard-
ized cell suspension.
2.2. Catheter-Associated C. albicans Bioﬁlm Formation. The
ﬁrst step was to prepare the substrate material (silicone elas-
tomer) for bioﬁlm formation. Silicone elastomer (SE) sheets
were obtained from Invotec International (Jacksonville,
FL, USA). Following the manufacturer’s instructions,
the catheter material sheet was cleaned by scrubbing
it thoroughly with a clean, soft-bristled brush in a hot
water/hand soap solution, rinsed with distilled water, and
autoclaved. Flat circular discs 15mm in diameter were
obtained by cutting through the catheter sheets with a cork
borer, as pre-viously described [28]. The sterile SE disks
were distrib-uted into 12-well plates, precoated with fetal
bovine serum (Mediatech, VA, USA) for 24h at 37◦Co n
a rocker table and then exposed to one of the Candida
strains (1 × 107 cells/mL). To assist C. albicans adhesion,
the SE discs were incubated at 37◦C for 90min, transferred
to a sterile 12-well plate containing 4mL of yeast nitrogen
base medium, and subsequently cultured at 37◦Cf o r4 8h .
Bioﬁlm formation was quantiﬁed by means of a tetrazoli-
um XTT [2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide] reduction assay [28]. Discs
containing no Candida cells served as controls. To conﬁrm
bioﬁlm formation, the Candida-seeded SE discs were trans-
ferred to microscope slides, stained with calcoﬂuor-white
(0.05% (vol/vol)) and examined under a ﬂuorescence micro-
scope at λmax = 432nm.
2.3. Engineering Human Oral Mucosa Production. Gingival
mucosa samples were biopsied from healthy donors follow-
ing their informed consent and approval by the University
Lavals ethics committee. Gingival ﬁbroblasts and epithelial
cells were subsequently extracted [29]. Following culture, the
cells were used to engineer human oral mucosa (EHOM).
The ﬁbroblasts were mixed with bovine skin collagen to
produce the lamina propria. Four days later, the epithelial
cells were seeded on the lamina propria and grown until
conﬂuence. The EHOM was then raised to the air-liquid
interface for ﬁve days for epithelium stratiﬁcation and was
used thereafter to study C. albicans pathogenesis.
2.4. Tissue Structure following Infection. EHOM was ﬁrst
grown in a serum-free, antifungal-free DMEH medium for
48h and then placed in contact with one of the C. albicans
(104 cells/cm2)strainsfor24h.NoninfectedEHOMwasused
as the control (Ctrl). Following infection and culture, the
biopsies were collected, ﬁxed with 4% paraformaldehyde
solution, embedded in paraﬃn, and stained with hematox-
ylineosin for analysis.
2.5. Quantitation of the Bioﬁlms Formed on the EHOM Tissue.
To quantitatively assess the diﬀerences in bioﬁlm forma-
tion by the selected C. albicans strains, multiple specimensMediators of Inﬂammation 3
Table 1: Candida strains used in this study.
Strain Relevant characteristics Reference
CAF2-parental strain URA3/Δura3::imm43 [16]
RML1-heterozygous ecm33 mutant CaECM33/ΔCaecm33:: hisG-CaURA3-hisG [17]
RML2-homozygous double ecm33 mutant ΔCaecm33Δ:: hisG/Caecm33Δ:: hisG-CaURA3-hisG [17]
RML3-heterozygous revertant Caecm33Δ:: hisG/CaECM33-clz-URA3-clz-hisG [17]
RML4-homozygous revertant CaECM33-clz-hisG/CaECM33-clz-URA3-clz-hisG [17]
Table 2: Description of oligonucleotide primer pairs used in PCR reactions.
Gene Primer sequence (5  to 3 ) Amp size
(bp)
Bax Sens 5 -TGG CAG ACA TGT TTT CTG AC-3 
204
Antisens 5 -TCA CCC AAC CAC CCT GGT CTT-3 
Bcl2 Sens 5 -TTT GAG TTC GGT GGG GTC AT-3 
274
Antisens 5 -TGA CTT CAC TTG TGG CCC AG-3 
GAPDH Sens 5 -ATGCAACGGATTTGGTCGTAT-3 
221
Antisens 5 -TCTCCTCCTGGAAGATGGTG-3 
were collected from each infected EHOM and stained with
hematoxylin-eosin. Each slide was assigned a number, and
measurements were made independently by two diﬀerent
observers. Each blind observer measured the thickness of
C. albicans bioﬁlms at regular intervals using a calibrated
image analysis system (Image-Pro Plus software, Media
Cybernetics, MD, USA), as we previously reported [30].
Ten measurements were performed on the unfolded area of
each slide. We then compared the thickness of the bioﬁlms
formed on the EHOM specimens infected with the mutant
strains and that of the bioﬁlms formed by the wild-type
and revertant strains. A P value of <0.05 was considered
statistically signiﬁcant (n = 4).
2.6. Lactate Dehydrogenase Assay. The release of lactate de-
hydrogenase (LDH) from the EHOM into the surrounding
medium was monitored as a measure of tissue damage/cell
necrosis. LDH activity release into the medium of the infect-
ed tissue (IT) was measured at 24h using a Cytox96 kit
(Promega, Madison, WI, USA) according to the manufac-
turer’s instructions. A positive control (PC) was obtained by
culturing the cells for one hour in the presence of 1% Triton
X-100, while a negative control (NC) was obtained by cul-
turing cells not exposed to any Candida strain. LDH activity
wascalculatedasthepercetageoftotalLDHactivityrelease =
(ITabsorbance−NCabsorbance)/(PCabsorbance−NCabsorbance)×100.
Diﬀerences between groups were determined by an ANOVA
Student t-test and was considered signiﬁcant at a P value of
<0.05 (n = 4).
2.7. Apoptotic (Bax) and Antiapoptotic (Bcl-2) Gene Expres-
sion and Protein Production. Following EHOM infection
with the Candida strains, total RNA was extracted from
each EHOM and used to comparatively analyze Bax and
Bcl2 gene expression by qRT-PCR [31]a n dG A P D Hg e n e
expression. Table 2 presents the speciﬁc primer sequences
used in this study. The thermocycling conditions for the Bax
gene were 95◦C for 5min, followed by 40 cycles of 95◦C
for 15s, 64◦C for 30s, and 72◦C for 30s, while those for
the Bcl2 gene were 95◦C for 3min, followed by 40 cycles of
95◦C for 10s, 64◦C for 10s, and 72◦C for 30s. The speciﬁcity
of each primer pair was veriﬁed by the presence of a
singlemeltingtemperaturepeak.GAPDHproduceduniform
expressionlevelsvaryingbylessthan0.5CTsbetweensample
conditions and was therefore used as a reference gene for
this study. Gene expression was supported by Bax and
Bcl2 protein analyses. Candida-infected EHOM was used to
prepare protein cell lysates which were then subjected to SDS
polyacrylamide gel electrophoresis and electroblotting onto
PVDF membranes [31]. The membranes were then blocked
with 5% BSA in Tween-20/Tris-buﬀered saline (TTBS) for
1h and were incubated overnight at 4◦C with either primary
anti-Bax or anti-Bcl2 antibodies (1:1000). After washing,
themembraneswereincubatedwithhorseradishperoxidase-
labeled secondary antibody (1:1000) for 1h. For protein
detection, the membranes were washed for 3h with TBS,
incubated in ECL, and analyzed on a Fujiﬁlm Image Reader
LAS-1000 Pro.
2.8. Laminin 5 and Type IV Collagen Protein Production.
Following contact for 24h with one of the Candida strains,
the EHOM protein lysates were used to assess laminin 5
and type IV collagen production by western blotting using
mouseantilaminin5(1:200)ormouseantitypeIVcolla-gen
(1:1000). Each membrane was washed in TBS-T then in-
cubated with the appropriate secondary horseradish perox-
idase-labeled antibody (1:1000) for 1h at 23◦C. Protein
detection was performed as described above.
3. Results
3.1. Caecm33 Mutant Formed Less Bioﬁlms. Our ﬁndings
show that homozygous Caecm33 mutant tended to form less4 Mediators of Inﬂammation
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Figure 1: Bioﬁlm-forming ability of isogenic wild-type, Caecm33 mutant, and revertant strains. (a) Metabolic activity of mature bioﬁlms
formed by the isogenic strains. (b–d) Fluorescence micrographs showing diﬀerences in morphology of bioﬁlms formed by (b) wild-type,
(c) ECM33 mutant, or (d) revertant strain. RML1-heterozygous Caecm33/CaECM33 mutant; RML2-homozygous Caecm33 mutant; RML3-
heterozygous Caecm33/CaECM33 revertant; RML4-homozygous ECM33/ECM33 revertant.
bioﬁlms than did the isogenic wild-type strain (P = 0.052,
Figure 1(a)). Fluorescence microscopy results also reveal that
the bioﬁlms formed by Caecm33 mutant were less dense and
contained patchy clusters of a diﬀuse extracellular matrix,
compared to that observed in the isogenic wild-type and
revertant strains (Figures 1(b)–1(d)).
3.2. Eﬀect of the Caecm33 Mutants on the EHOM Structure.
The noninfected EHOM showed a well-organized epithelial
structure characterized by diﬀerent epithelial cell layers
and a ﬁbroblast-populated lamina propria (Figure 2(a)).
Following infection with the CAF2 (Figure 2(b))a n dR M L 4 -
homozygous revertant strains (Figure 2(f)), the EHOM dis-
played a thinner, more disorganized epithelium comprised
of diﬀerentiated cells (i.e., large vacuolated cells containing
a large nucleus). The mutation of one Caecm33 allele
partially prevented tissue damage (Figures 2(c) and 2(e)).
The epithelium in the RML2-homozygous double Caecm33
mutant-infected EHOM (Figure 2(d)) continued to display
a stratiﬁed appearance. Close examination of the EHOM-
infectedtissuesrevealedtheformationofbioﬁlmscontaining
both forms of Candida (yeast and hyphae) on the outer layer
of the epithelium (Figure 2). Bioﬁlm analysis showed that
the CAF2 and RML4-homozygous revertant Candida strains
formed signiﬁcant bioﬁlms on the EHOM layers, resulting in
disorganized tissue layers, whereas the RML1-heterozygous
Caecm33 mutant, the RML2-homozygous double Caecm33
mutant, and the RML3-heterozygous revertant strains all
formed less bioﬁlms on the EHOM epithelium (Figure 2),
thus causing less damage. Quantitative analysis revealed that
the bioﬁlms formed by the Caecm33 mutants were thinner
than those formed by the CAF2 and RML4-homozygous
revertant strains (Figure 3). Of interest is that the thinnest
bioﬁlms were obtained with the RML2-homozygous doubleMediators of Inﬂammation 5
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Figure 2: Interaction of ECM33 mutants with EHOM and bioﬁlm formation. Histological features of the EHOM following 24 h of
exposure to each C. albicans strain. (a) Noninfected EHOM tissue; (b) infected with CAF2 strain; (c) RML1; (d) RML2; (e) RML3; (f)
RML4 C. albicans. The noninfected EHOM (a) displays an epithelium (Ep) containing a stratum corneum layer (SC), a basal layer (BL),
and a collagen-containing lamina propria (LP) populated with ﬁbroblasts (arrows). Scale bars, 30μm. Representative photographs of three
diﬀerent experiments are shown (two EHOMs per experiment).
Caecm33mutant strain.These studies show thata disruption
of the ECM33 gene resulted in a diminished ability of C.
albicans to form bioﬁlms (Figure 3) and to damage the host
mucosal tissue.
3.3. Toxicity of the Caecm33 Mutants on the EHOM Tissue.
As Caecm33 mutants led to less tissue damage and reduced
bioﬁlm formation on the EHOM, we investigated the eﬀect
of each Candida strain on the release of LDH by the EHOM
cells. It was observed (Figure 4) that infection of the EHOM
with the CAF2 strain and the RML4-homozygous revertant
strain resulted in high levels of LDH in the medium, which is
in agreement with our observations of the damaged epithe-
lium (Figure 2) obtained with the CAF2 strain. It should be
noted that each Caecm33 mutant negatively aﬀected LDH
release by the EHOM compared to that observed with the
CAF2 strain (Figure 4).
3.4. Apoptotic Gene Expression and Protein Production by the
EHOM following Infection with Caecm33 Mutant C. albi-
cans . The CAF2 and RML4-homozygous revertant strains
signiﬁcantly increased the Bax/Bcl2 gene expression ratio
compared to that recorded by the noninfected EHOM. This
was due to increased Bax gene expression which is an
indicator of cell apoptosis. Following EHOM infection with
the Caecm33 mutants, Bax gene expression signiﬁcantly (P<
0.01) decreased compared to that observed with the CAF2-
infected tissue (Figure 5(a)). Furthermore, Caecm33 double
mutant recorded the lowest level of Bax gene expression.
RT-PCR analyses of Bcl2 gene showed that its expression6 Mediators of Inﬂammation
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Figure 3: Eﬀect of ECM33 gene on the ability of C. albicans to form bioﬁlm on EHOM. Following infection with each Candida strain
and culture for 24h, a quantitative assessment of the thickness of the bioﬁlm formed on the EHOM tissues was performed. Means + SD
(n = 4) were plotted. Diﬀerences were obtained by comparing the bioﬁlms obtained with the CAF2 strain and the other Candida strains.
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Figure 4: LDH release following EHOM infection with C. albicans strains. Culture media were collected from the noninfected and infected
EHOMs. Supernatants were used to assess LDH release by means of speciﬁc kits. Data are means + SD, n = 5. ∗∗P<0.01 compared to the
control (CAF2-infected EHOM).
remainedunchangedfollowingtissueinfectionwithallofthe
Candida strains under study (Figure 5(b)). These ﬁndings
aresupportedbyBaxandBcl2proteinanalysesusingwestern
blotting. Figure 6 shows that Bcl2 was unchanged; however,
Bax protein was highly present in the EHOM infected
with the CAF2 and RML4-homozygous strains compared to
the noninfected and Caecm33 mutant-infected specimens.
Overalldataindicatethatapoptoticgenesandproteins’levels
of expression increased when the tissues were infected with
CAF2.Infectionwiththemutantstrainsneverthelessshowed
a reduction in apoptotic gene and protein expression, which
may prevent mammalian cell death/apoptosis.
3.5. The C. albicans Strains Modulated Laminin 5 and Type
IV Collagen Synthesis. Western blot results show elevated
basal levels of laminin 5 and type IV collagen proteins in
the noninfected EHOM (Figure 7(a)), whereas both proteins
were signiﬁcantly (P<0.05) down regulated in the infected
tissues. It is important to note that all of the tested Candida
strainssigniﬁcantlydecreasedlaminin5andtypeIVcollagenMediators of Inﬂammation 7
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Figure 5: Bax and Bcl2 expression following EHOM infection with C. albicans strains. Total RNAs were extracted from the infected EHOMs
and analyzed by RT-PCR for Bax and Bcl2 gene expression. Data are means + SD, n = 5. ∗P<0.05; ∗∗P<0.01 signiﬁcance between the
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Figure 6: Bax and Bcl2 protein analyses following EHOM infection with C. albicans strains. Total proteins were extracted from the infected
EHOMs and analyzed by western blotting for Bax and Bcl2 production. Gels are representative (n = 5).
levels in the infected EHOM (Figure 7(b)) compared to the
noninfected specimens. Thus ECM33 gene mutation did not
prevent the laminin 5 and type IV collagen decreases.
4. Discussion
C. albicans adhesion to various surfaces, including mucosal
tissue and catheter disks, is the ﬁrst step in bioﬁlm formation
and host infection [32, 33]. Our study demonstrates that the
Candida adhesion to and bioﬁlm formation on catheter discs
were modulated by ECM33 gene, and that the disruption
of this gene led to decreased bioﬁlm formation, which
supports previously reported data with medical devices [3,
34]. Thus adhesion and bioﬁlm formation on a catheter
that is in contact with host tissue may contribute to tissue
disorganization and facilitate yeast penetration into the deep
tissue and subsequent systemic invasion [35].
C. albicans adhesion to mammalian cells and tissue is
under the control of various genes, such as ECM33. Using an
EHOM model, we demonstrated that Caecm33 mutant was
unable to damage tissue structure, compared to the CAF2
strains. This inability to cause tissue damage may be linked
to a defect in the ability of Caecm33 mutant to form hyphae.
Indeed, it was reported that Caecm33 mutants displayed
ﬁlamentation defects in both liquid and solid media [17].
The inability of ECM33 mutant to damage the EHOM tissue
may also be due to cell wall architectural changes that
hamper interactions with host cell/tissue. Caecm33 mutants
have in fact been shown to exhibit signiﬁcant cell changes,
includinganabnormallyelectron-denseoutermannoprotein
layer [17]. This architectural modiﬁcation likely contributed
to the reduced adherence level, decreased bioﬁlm formation,
and less extensive tissue damage observed in this study.
Caecm33 mutants were also less capable of promoting
cell death/apoptosis by reducing LDH release and Bax
gene expression. These ﬁndings support the reduced tissue
disorganization when placed in contact with the Caecm33
mutants. Recent studies suggest that the decreased host cell
damage caused by Caecm33 mutants is likely due in part to
thereducedendocytosisofthesestrains[8].Caecm33mutant
strains may also secrete less lytic enzymes, such as secreted
aspartyl proteases and phospholipases [8], thus contributing
to the host tissue cell damage defect of these mutants.
Further studies are necessary to determine the mechanisms
underlying the decreased virulence of the Caecm33 mutant
strains.
EHOM disorganization following contact with the
ECM33-positive gene may also modulate some physiological8 Mediators of Inﬂammation
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Figure 7: C. albicans downregulated basement membrane protein production. Total proteins were extracted from the infected EHOMs
and analyzed by western blotting for the presence of laminin 5 and type IV collagen. (a) Representative gel of three separate experiments.
Unstimulated tissue was used as a control (Ctrl). Protein production modulation was determined by band scanning using public domain
NIH Image software. (b) Histograms are the means + SD (n = 4). Statistical diﬀerences were found by comparing the values obtained from
the infected and noninfected tissues. ∗∗P<0.01.
mechanisms such as BM protein production. Indeed, follow-
ingcontactwiththeCAF2andCaecm33mutantstrains,both
laminin 5 and type IV collagen levels decreased signiﬁcantly.
By decreasing BM protein production, Candida may thus
deregulate epithelial and connective tissue structural interac-
tions, thereby reducing their capacity to prevent its invasion
[36]. It has been shown that Candida invasion requires
adhesion to BM proteins as well as their degradation [21].
Although Candida is capable of degrading these proteins,
this does not necessarily mean that Caecm33 mutant will, in
turn, downregulate laminin 5 and type IV collagen protein
production. The deletion of single or double Caecm33 alleles
ledtothesameeﬀectasthatproducedbytheCAF2strainson
BM protein expression. This suggests that ECM33 mutation
does not reduce the ability of Candida to decrease BM
protein synthesis by gingival cells. Further research will be
conducted to shed light on this possible mechanism.
In conclusion, we used an engineered human oral mu-
cosa model to demonstrate that Caecm33 mutant was not
able to damage tissue structure and promote cell apoptosis.
Wealsodemonstratedthatbioﬁlmformationwasreducedby
Caecm33 mutants compared to parental strains. Finally, we
showed that parental and Caecm33 mutant strains downreg-
ulated laminin 5 and type IV collagen production. Overall
data thus suggest that ECM33 gene plays an active role in
Candida-host interactions and is responsible for tissue dam-
age that ultimately leads to candidiasis.
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